Stock & Company Details
Altimmune Inc $ALT
Price:
N/A
N/A
195M
$408M
52 Week High:
N/A
10 Day Average Volume:
N/A
-2.32
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Commercial Services
ALT technical indicators
Latest Altimmune Inc (ALT) indicator readings as of 2026-10-29.
ALT's 14-day RSI is 30.0, in oversold territory. At $2.14 it is trading 35.0% below its 200-day moving average of $3.29, and below its 50-day average of $2.84. Price sits in the middle of its Bollinger Bands ($1.90 to $2.82). ADX reads 41.2, indicating a trending market.
Overview
Altimmune Inc is engaged on developing treatments for obesity and liver diseases. The Company's pipeline includes next generation peptide therapeutics for obesity and non-alcoholic steatohepatitis (NASH) (for both, pemvidutide, formerly known as ALT-801), and for chronic hepatitis B (HepTcell). The Company is managed and operates as a single business focused on the research and development of treatments for various diseases and disorders, and vaccines.
Finance Bot
Ask your questions
Start by typing a question below.
